Using Residence Time Distributions (RTDs) to Address the Traceability of Raw Materials in Continuous Pharmaceutical Manufacturing

Continuous processing in pharmaceutical manufacturing is a relatively new approach that has generated significant attention. While it has been used for decades in other industries, showing significant advantages, the pharmaceutical industry has been slow in its adoption of continuous processing, primarily due to regulatory uncertainty. This paper aims to help address these concerns by introducing methods for batch definition, raw material traceability, and sensor frequency determination. All of the methods are based on established engineering and mathematical principles, especially the residence time distribution (RTD). This paper introduces a risk-based approach to address content uniformity challenges of continuous manufacturing. All of the detailed methods are discussed using a direct compaction manufacturing line as the main example, but the techniques can easily be applied to other continuous manufacturing methods such as wet and dry granulation, hot melt extrusion, capsule filling, etc.

[1]  P. V. Danckwerts Continuous flow systems. Distribution of residence times , 1995 .

[2]  Roger Nosal,et al.  PQLI Key Topics - Criticality, Design Space, and Control Strategy , 2008, Journal of Pharmaceutical Innovation.

[3]  Fernando J. Muzzio,et al.  Characterizing continuous powder mixing using residence time distribution , 2011 .

[4]  Chris Potter,et al.  PQLI Application of Science- and Risk-based Approaches (ICH Q8, Q9, and Q10) to Existing Products , 2009, Journal of Pharmaceutical Innovation.

[5]  Gintaras V. Reklaitis,et al.  Exceptional Events Management Applied to Roller Compaction of Pharmaceutical Powders , 2010, Journal of Pharmaceutical Innovation.

[6]  Fernando J. Muzzio,et al.  Characterization of continuous convective powder mixing processes , 2008 .

[7]  Gregory R. Ziegler,et al.  Residence time distribution in a co-rotating, twin-screw continuous mixer by the step change method , 2003 .

[8]  Soon Huat Tan,et al.  Cytocompatibility and Mechanical Properties of Hydroxyapatite Composite Reinforced with Multi-Walled Carbon Nanotubes and Bovine Serum Albumin , 2013 .

[9]  Thomas F. Coleman,et al.  On the convergence of interior-reflective Newton methods for nonlinear minimization subject to bounds , 1994, Math. Program..

[10]  P. Poechlauer,et al.  Continuous Processing in the Manufacture of Active Pharmaceutical Ingredients and Finished Dosage Forms: An Industry Perspective , 2012 .

[11]  P. V. Danckwerts Continuous flow systems , 1953 .

[12]  Karl Sommer,et al.  Possibilities to improve the short-term dosing constancy of volumetric feeders , 2003 .

[13]  Thomas F. Coleman,et al.  An Interior Trust Region Approach for Nonlinear Minimization Subject to Bounds , 1993, SIAM J. Optim..

[14]  Fernando J. Muzzio,et al.  A review of the Residence Time Distribution (RTD) applications in solid unit operations , 2012 .

[15]  Marianthi G. Ierapetritou,et al.  An integrated approach for dynamic flowsheet modeling and sensitivity analysis of a continuous tablet manufacturing process , 2012, Comput. Chem. Eng..

[16]  Rohit Ramachandran,et al.  Model-Based Control-Loop Performance of a Continuous Direct Compaction Process , 2011, Journal of Pharmaceutical Innovation.

[17]  John C. Berridge,et al.  PQLI ®: Current Status and Future Plans , 2009, Journal of Pharmaceutical Innovation.

[18]  Hans Leuenberger,et al.  Batch And Continuous Processing In The Production Of Pharmaceutical Granules , 2003, Pharmaceutical development and technology.

[19]  Rex B. Thorpe,et al.  Particle residence time distributions in circulating fluidised beds , 2003 .

[20]  Guidance for Industry PAT — A Framework for Innovative Pharmaceutical Development , Manufacturing , and Quality Assurance , 2004 .

[21]  Fernando J. Muzzio,et al.  Effects of powder flow properties and shear environment on the performance of continuous mixing of pharmaceutical powders , 2013 .

[22]  H Leuenberger,et al.  New trends in the production of pharmaceutical granules: batch versus continuous processing. , 2001, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[23]  Joel M. Hawkins,et al.  Continuous Processing in the Pharmaceutical Industry , 2010 .

[24]  Fernando J. Muzzio,et al.  Quantitative characterization of mixing processes in rotary calciners , 2002 .

[25]  Marianthi G. Ierapetritou,et al.  Characterization of feeder effects on continuous solid mixing using fourier series analysis , 2011 .

[26]  Peter Glavič,et al.  Design of Batch Versus Continuous Processes: Part I: Single-Purpose Equipment , 1997 .

[27]  Fernando J. Muzzio,et al.  Method for characterization of loss-in-weight feeder equipment , 2012 .

[28]  Marina Bosch,et al.  Elements Of Chemical Reaction Engineering , 2016 .

[29]  K. Plumb,et al.  Continuous Processing in the Pharmaceutical Industry: Changing the Mind Set , 2005 .

[30]  Vadim Mizonov,et al.  Influence of stirrer type on mixture homogeneity in continuous powder mixing: A model case and a pharmaceutical case , 2008 .

[31]  Lakshman Pernenkil,et al.  A review on the continuous blending of powders , 2006 .

[32]  Vadim Mizonov,et al.  FLOW ANALYSIS AND MARKOV CHAIN MODELLING TO QUANTIFY THE AGITATION EFFECT IN A CONTINUOUS POWDER MIXER , 2006 .

[33]  Martin Warman,et al.  Continuous Processing in Secondary Production , 2010 .